University of Cincinnati Medical Center, LLC

University of Cincinnati Medical Center, LLC was paid $176.53M by Medicaid between Jan 2018 and Dec 2024, across 920 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 15% of everything it billed.

33Billing provider infoUNIVERSITY OF CINCINNATI MEDICAL CENTER, LLC
CINCINNATI, OH 45219

33aNPI1033154026assigned 06/17/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$176.53M

24GClaims3,755,175

24DCodes billed920

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#5 of 101

Median peer was paid$22.32M

This provider vs. median7.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	467,342	$13.72M
2019	408,847	$11.82M
2020	266,376	$13.06M
2021	288,566	$15.13M
2022	292,821	$16.42M
2023	1,112,949	$61.74M
2024incomplete	918,274	$44.63M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	15%	263,113	214,334	$26.05M
J2350	Injection, ocrelizumab, 1 mg	8.5%	729	548	$15.04M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	7.9%	238,472	199,682	$13.89M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.9%	58,138	49,432	$8.58M
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	4.5%	1,489	1,236	$7.87M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.4%	49,635	44,412	$5.97M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.3%	32,076	25,657	$5.78M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	3.0%	32,614	23,680	$5.30M
J9271	Injection, pembrolizumab, 1 mg	2.6%	735	505	$4.57M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	1.4%	1,332	801	$2.38M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1.2%	792	364	$2.20M
G0378	Hospital observation service, per hour	1.2%	21,699	10,851	$2.20M

908 more codes

96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.2%	7,276	$2.19M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.2%	6,319	$2.13M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.1%	12,476	$2.03M
J2323	Injection, natalizumab, 1 mg	1.1%	408	$1.97M
J0585	Injection, onabotulinumtoxina, 1 unit	1.1%	3,481	$1.97M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.1%	18,946	$1.96M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.0%	14,266	$1.81M
96361	Intravenous infusion, hydration; each additional hour	1.0%	6,940	$1.77M
59025	Fetal non-stress test	<1%	10,908	$1.74M
80053	Comprehensive metabolic panel	<1%	133,028	$1.56M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	12,662	$1.51M
76819	Fetal biophysical profile; without non-stress testing	<1%	14,652	$1.40M
70450	Computed tomography, head or brain; without contrast material	<1%	6,197	$1.39M
36415	Collection of venous blood by venipuncture	<1%	322,978	$1.15M
20610		<1%	7,208	$998K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	3,985	$989K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	8,178	$910K
96415		<1%	2,891	$805K
99213	Doctor's office visit, returning patient (routine)	<1%	8,587	$787K
D7140	Extraction, erupted tooth or exposed root	<1%	3,179	$663K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	24,771	$592K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,122	$589K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	5,209	$589K
64615		<1%	2,310	$572K
84443	Thyroid stimulating hormone (TSH)	<1%	46,908	$560K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,988	$554K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	949	$533K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	154,253	$522K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	8,289	$521K
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	364	$505K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,282	$496K
93308		<1%	1,899	$475K
83036	Hemoglobin; glycosylated (A1C)	<1%	61,003	$467K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,326	$462K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	7,319	$455K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	30,158	$455K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	3,598	$451K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	19,714	$444K
77386		<1%	1,123	$443K
78815	Positron emission tomography (PET) for limited area imaging	<1%	577	$427K
76801		<1%	3,304	$423K
80061	Lipid panel	<1%	42,451	$405K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	5,229	$404K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	6,674	$402K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	19,707	$396K
85027		<1%	70,348	$390K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,303	$388K
96375	Therapeutic injection; each additional sequential IV push	<1%	19,075	$379K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	13,003	$371K
80048	Basic metabolic panel (calcium, ionized)	<1%	52,116	$369K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	27,791	$368K
99214	Doctor's office visit, returning patient (more involved)	<1%	5,557	$352K
87536		<1%	8,732	$345K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	43,461	$344K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	317	$333K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	24,237	$332K
82805		<1%	9,640	$318K
93458		<1%	355	$317K
87800		<1%	8,758	$313K
70496		<1%	1,093	$312K
90677		<1%	2,168	$306K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,410	$299K
90837	Psychotherapy session, about an hour	<1%	2,603	$298K
86850		<1%	18,715	$297K
93798		<1%	4,846	$288K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	684	$284K
31231		<1%	1,325	$271K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	485	$270K
36430		<1%	1,657	$268K
77300		<1%	562	$261K
86780		<1%	21,917	$259K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,881	$254K
80069		<1%	31,631	$250K
41899	Unlisted procedure, dentoalveolar structures	<1%	663	$249K
77334		<1%	618	$243K
87902		<1%	1,426	$240K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	590	$238K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,413	$237K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,161	$229K
71045	Radiologic examination, chest; single view	<1%	17,199	$218K
71046	Radiologic examination, chest; 2 views	<1%	13,534	$217K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,526	$216K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,324	$213K
31579		<1%	925	$213K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	823	$206K
99215	Doctor's office visit, returning patient (complex)	<1%	1,913	$203K
49083		<1%	581	$202K
71271		<1%	1,213	$198K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,553	$198K
D7240	Removal of impacted tooth - completely bony	<1%	1,190	$198K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	860	$195K
86803		<1%	22,213	$193K
71250		<1%	1,825	$190K
86355		<1%	6,713	$188K
82248		<1%	52,933	$185K
82607		<1%	15,219	$183K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	19,877	$182K
D1110	Prophylaxis - adult	<1%	4,939	$181K
62323		<1%	446	$180K
36512		<1%	222	$178K
J2357	Injection, omalizumab, 5 mg	<1%	279	$177K
87086	Culture, bacterial; quantitative colony count, urine	<1%	24,103	$170K
86900		<1%	19,526	$170K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,000	$168K
J9312	Injection, rituximab, 10 mg	<1%	58	$168K
82728		<1%	16,146	$167K
70355		<1%	6,576	$162K
70491		<1%	618	$161K
20611		<1%	567	$157K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,018	$157K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	919	$156K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,536	$154K
84439		<1%	14,264	$153K
76820		<1%	2,687	$152K
86360		<1%	6,690	$152K
31575		<1%	1,076	$152K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	2,474	$149K
67028	Intravitreal injection of a pharmacologic agent	<1%	810	$147K
83735		<1%	43,201	$145K
87340		<1%	14,659	$143K
86480		<1%	4,867	$143K
77336		<1%	1,166	$140K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	292	$139K
95886		<1%	1,327	$135K
86359		<1%	6,713	$132K
77301		<1%	153	$132K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	557	$132K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,025	$129K
J0485	Injection, belatacept, 1 mg	<1%	575	$128K
96900		<1%	3,745	$126K
99204	Doctor's office visit, new patient (more involved)	<1%	1,611	$126K
87522	Neg quan hep c or qual rna	<1%	5,291	$126K
83880		<1%	13,274	$125K
91200		<1%	1,203	$123K
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	<1%	471	$122K
J0897	Injection, denosumab, 1 mg	<1%	259	$121K
43235		<1%	289	$118K
72141		<1%	757	$116K
76642		<1%	971	$114K
90686		<1%	8,210	$113K
0002A		<1%	3,523	$108K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,441	$107K
92557		<1%	2,133	$105K
J0185	Injection, aprepitant, 1 mg	<1%	827	$104K
96416		<1%	785	$104K
97162		<1%	2,210	$103K
90832	Psychotherapy session, about 30 minutes	<1%	1,220	$103K
93017		<1%	1,162	$102K
93296		<1%	5,128	$101K
64483		<1%	207	$100K
11721		<1%	3,809	$99K
84100		<1%	30,352	$98K
86140		<1%	13,684	$96K
95910		<1%	400	$96K
76770		<1%	699	$96K
72100		<1%	4,584	$96K
82570		<1%	23,684	$95K
83970		<1%	5,153	$95K
90834	Psychotherapy session, about 45 minutes	<1%	902	$94K
85610		<1%	29,832	$94K
76536		<1%	1,005	$94K
90651		<1%	687	$93K
51798		<1%	2,435	$93K
41874		<1%	118	$92K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,760	$92K
81001		<1%	39,788	$92K
86317		<1%	7,902	$92K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	3,169	$91K
83540		<1%	15,670	$91K
73030		<1%	4,429	$90K
59430		<1%	1,214	$89K
72197		<1%	338	$89K
0001A		<1%	3,359	$88K
83550		<1%	15,273	$88K
93975		<1%	730	$88K
76830	Ultrasound, transvaginal	<1%	2,161	$86K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	79	$86K
52000		<1%	116	$86K
0352U		<1%	4,445	$85K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	22,376	$84K
70498		<1%	1,134	$83K
D0120	Dental checkup, returning patient	<1%	4,468	$83K
88307		<1%	918	$83K
90870		<1%	241	$83K
84484		<1%	18,897	$82K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	7,437	$81K
99218		<1%	273	$81K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	20	$80K
86762		<1%	5,722	$79K
A0425	Ground mileage, per statute mile	<1%	7,031	$79K
73221		<1%	346	$79K
90715		<1%	4,675	$78K
70486		<1%	958	$77K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,438	$76K
80197		<1%	8,905	$76K
81003		<1%	19,875	$76K
74183		<1%	354	$75K
94618		<1%	929	$75K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,927	$75K
81025		<1%	16,518	$74K
96376		<1%	4,423	$73K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,033	$73K
73630		<1%	4,145	$72K
95908		<1%	398	$72K
93971		<1%	841	$72K
95811		<1%	138	$71K
57454		<1%	299	$71K
73610		<1%	3,329	$71K
A0436	Rotary wing air mileage, per statute mile	<1%	362	$70K
97166		<1%	1,424	$69K
87653		<1%	3,932	$69K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	871	$69K
95885		<1%	374	$68K
76000		<1%	927	$67K
D9222		<1%	765	$67K
93970		<1%	396	$66K
96127		<1%	1,341	$65K
84702		<1%	5,098	$64K
H1000	Prenatal care, at-risk assessment	<1%	1,244	$63K
97161		<1%	1,187	$63K
80305		<1%	3,232	$62K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	290	$62K
94010		<1%	837	$62K
G0008	Administration of influenza virus vaccine	<1%	11,266	$62K
96417		<1%	1,840	$60K
86901		<1%	19,488	$60K
99203	Doctor's office visit, new patient (routine)	<1%	917	$59K
36591		<1%	5,245	$59K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	159	$59K
73130		<1%	3,030	$59K
10060		<1%	369	$58K
88341		<1%	1,293	$58K
J3490	Unclassified drugs	<1%	3,715	$57K
D0330	Panoramic radiographic image	<1%	1,340	$56K
80306		<1%	6,808	$56K
90791	Psychiatric diagnostic evaluation	<1%	324	$56K
J7050	Infusion, normal saline solution, 250 cc	<1%	24,013	$56K
96367		<1%	1,700	$55K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	3,147	$55K
73560		<1%	3,241	$54K
64643		<1%	265	$54K
97165		<1%	1,040	$54K
80320		<1%	4,131	$53K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	74	$53K
80076		<1%	6,363	$52K
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	4,495	$51K
90734		<1%	440	$50K
J1756	Injection, iron sucrose, 1 mg	<1%	1,616	$50K
74018		<1%	2,542	$50K
84403		<1%	3,108	$50K
77412		<1%	298	$49K
12001		<1%	346	$49K
D0140	Limited oral evaluation - problem focused	<1%	2,086	$48K
94060		<1%	851	$48K
95909		<1%	258	$48K
75561		<1%	180	$47K
77080		<1%	716	$47K
D0274	Bitewings - four radiographic images	<1%	2,264	$47K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	397	$46K
87077		<1%	7,099	$46K
84153		<1%	4,481	$45K
73590		<1%	2,386	$45K
73564		<1%	2,376	$44K
J3032	Injection, eptinezumab-jjmr, 1 mg	<1%	30	$44K
78431		<1%	76	$44K
86704		<1%	5,737	$43K
11056		<1%	354	$43K
93299		<1%	2,111	$43K
87517		<1%	2,353	$42K
36561		<1%	44	$42K
97116		<1%	1,401	$41K
D0150	Comprehensive oral evaluation - new or established patient	<1%	1,677	$41K
76937		<1%	1,184	$41K
94726		<1%	999	$41K
85652		<1%	13,309	$39K
82746		<1%	5,373	$39K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	13,589	$39K
73562		<1%	2,561	$39K
73700		<1%	255	$39K
99234		<1%	318	$39K
72040		<1%	1,894	$39K
82024		<1%	2,205	$39K
84480		<1%	4,325	$39K
82784		<1%	6,525	$38K
96523		<1%	1,017	$38K
82105		<1%	4,355	$38K
95816		<1%	227	$38K
90636		<1%	159	$37K
64493		<1%	51	$36K
86357		<1%	1,879	$36K
83921		<1%	3,175	$36K
86038		<1%	3,389	$36K
12002		<1%	231	$36K
J2704	Injection, propofol, 10 mg	<1%	26,139	$36K
84550		<1%	7,799	$35K
84156		<1%	15,715	$35K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	232	$35K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	61	$35K
72156		<1%	292	$34K
86235		<1%	3,415	$34K
82670		<1%	2,061	$34K
94729		<1%	1,257	$34K
77338		<1%	125	$33K
77290		<1%	77	$33K
95911		<1%	128	$33K
82043		<1%	8,054	$33K
12011		<1%	237	$33K
20550		<1%	245	$32K
83605		<1%	8,974	$32K
74178		<1%	120	$32K
93270		<1%	534	$32K
17250		<1%	243	$32K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	8,625	$31K
86160		<1%	2,964	$31K
88184		<1%	796	$31K
86790		<1%	3,440	$30K
73110		<1%	1,770	$30K
87070		<1%	3,831	$30K
83090		<1%	2,799	$30K
92550		<1%	335	$29K
95700		<1%	194	$29K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	2,468	$29K
84146		<1%	1,998	$29K
92083		<1%	644	$29K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	69	$29K
76818		<1%	394	$28K
D9223	Deep sedation/general anesthesia - each subsequent 15 minute increment	<1%	567	$28K
82565		<1%	4,672	$27K
87497		<1%	1,548	$26K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	20,604	$26K
29580		<1%	288	$26K
86592		<1%	3,275	$26K
73502		<1%	1,797	$26K
97535	Self-care/home management training, each 15 minutes	<1%	871	$25K
92134		<1%	1,101	$25K
83690		<1%	15,832	$25K
93922		<1%	490	$24K
83001		<1%	1,775	$24K
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	<1%	262	$24K
87186		<1%	5,280	$24K
73552		<1%	1,428	$24K
87506		<1%	179	$24K
72131		<1%	331	$23K
J0475	Injection, baclofen, 10 mg	<1%	47	$23K
97802		<1%	245	$23K
64642		<1%	514	$23K
64400		<1%	79	$23K
93242		<1%	261	$23K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	34	$22K
J1170	Injection, hydromorphone, up to 4 mg	<1%	12,310	$22K
72170		<1%	1,475	$22K
88185		<1%	729	$22K
82950		<1%	4,623	$22K
J1750	Injection, iron dextran, 50 mg	<1%	345	$22K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	1,604	$22K
86147		<1%	1,333	$22K
19083		<1%	26	$22K
97811		<1%	1,352	$22K
92526		<1%	485	$22K
86923		<1%	824	$22K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	12,580	$22K
83020		<1%	2,660	$21K
83883		<1%	2,230	$21K
94762		<1%	513	$21K
77065	Tomosynthesis, mammo	<1%	977	$20K
81373		<1%	292	$20K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	24	$20K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	332	$20K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	6,898	$20K
01999		<1%	1,692	$19K
0124A		<1%	793	$19K
91320		<1%	918	$19K
86225		<1%	1,727	$19K
J7030	Infusion, normal saline solution , 1000 cc	<1%	8,256	$18K
72082		<1%	959	$18K
82533		<1%	2,078	$18K
83615		<1%	5,869	$18K
86146		<1%	1,671	$18K
64721		<1%	24	$18K
82550		<1%	4,202	$18K
0004A		<1%	553	$17K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	808	$17K
77062		<1%	612	$17K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	371	$17K
76882		<1%	147	$17K
90472	Immunization administration, each additional vaccine (list separately)	<1%	3,533	$17K
92523		<1%	393	$17K
95976		<1%	193	$17K
J2315	Injection, naltrexone, depot form, 1 mg	<1%	14	$17K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,748	$17K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,959	$17K
86200		<1%	1,416	$17K
58661		<1%	51	$16K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	12,618	$16K
73090		<1%	1,042	$16K
D0220	Intraoral - periapical first radiographic image	<1%	2,995	$16K
77295		<1%	16	$16K
97810		<1%	737	$16K
D7220		<1%	101	$16K
31624		<1%	111	$15K
36416		<1%	4,675	$15K
76813		<1%	232	$15K
84402		<1%	817	$15K
82330		<1%	3,189	$15K
77061		<1%	660	$15K
11900		<1%	85	$15K
73070		<1%	988	$15K
72070		<1%	584	$15K
83520		<1%	1,885	$15K
83655		<1%	1,526	$15K
D7230		<1%	35	$14K
96132		<1%	195	$14K
86787		<1%	1,690	$14K
84703		<1%	5,965	$14K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	10,541	$14K
86870		<1%	441	$14K
86376		<1%	972	$14K
72110		<1%	809	$14K
73120		<1%	433	$14K
A4648	Tissue marker, implantable, any type, each	<1%	256	$14K
A0427	Emergency ambulance ride, advanced life support	<1%	88	$13K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	4,956	$13K
72157		<1%	136	$13K
86920		<1%	608	$13K
73620		<1%	741	$13K
86255		<1%	1,358	$13K
J2997	Injection, alteplase recombinant, 1 mg	<1%	182	$12K
96402		<1%	682	$12K
83002		<1%	1,026	$12K
81376		<1%	310	$12K
93451		<1%	15	$12K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	199	$12K
92250		<1%	381	$12K
87799		<1%	1,407	$12K
72050		<1%	520	$12K
86431		<1%	1,757	$12K
82627		<1%	491	$11K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	30	$11K
85730		<1%	4,479	$11K
83516		<1%	1,576	$11K
84425		<1%	1,104	$11K
92610		<1%	285	$11K
88342		<1%	2,755	$11K
86003		<1%	1,123	$11K
29581		<1%	62	$10K
90480		<1%	1,374	$10K
31615		<1%	15	$10K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	9,727	$10K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	1,327	$10K
73060		<1%	755	$10K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,954	$10K
90670		<1%	865	$10K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	247	$10K
D0210	Intraoral - complete series of radiographic images	<1%	215	$10K
92552		<1%	219	$10K
73600		<1%	488	$9K
90656		<1%	1,274	$9K
80164		<1%	1,208	$9K
64635		<1%	15	$9K
93325		<1%	135	$9K
J1644	Injection, heparin sodium, per 1000 units	<1%	9,301	$9K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	424	$9K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,462	$9K
86364		<1%	1,007	$9K
86832		<1%	267	$9K
80175		<1%	957	$9K
87040		<1%	1,905	$9K
83013		<1%	197	$9K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	57	$9K
83521		<1%	1,507	$9K
87210		<1%	3,750	$9K
72190		<1%	454	$9K
64494		<1%	69	$9K
86334		<1%	1,170	$9K
72146		<1%	90	$9K
90648		<1%	1,375	$9K
84520		<1%	1,550	$9K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,553	$9K
77066	Tomosynthesis, mammo	<1%	642	$9K
86709		<1%	1,162	$8K
86922		<1%	495	$8K
80321		<1%	902	$8K
80074		<1%	571	$8K
72128		<1%	146	$8K
86800		<1%	746	$8K
85014		<1%	3,513	$8K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	767	$8K
87205		<1%	2,790	$8K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	47	$8K
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	638	$8K
20553		<1%	45	$8K
84163		<1%	687	$8K
J9045	Injection, carboplatin, 50 mg	<1%	685	$8K
87900		<1%	76	$8K
84704		<1%	687	$8K
11055		<1%	79	$8K
51705		<1%	172	$7K
69210		<1%	179	$7K
00731		<1%	1,037	$7K
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,819	$7K
84134		<1%	807	$7K
86825		<1%	270	$7K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	508	$7K
84165		<1%	1,369	$7K
86735		<1%	712	$7K
93356		<1%	115	$7K
31622		<1%	15	$7K
36410		<1%	479	$7K
83993		<1%	476	$7K
J3489	Injection, zoledronic acid, 1 mg	<1%	562	$7K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,743	$7K
87901		<1%	64	$7K
82951		<1%	433	$7K
97129		<1%	90	$7K
86833		<1%	267	$7K
86677		<1%	731	$7K
00300		<1%	307	$7K
85576		<1%	854	$7K
76827		<1%	209	$7K
84630		<1%	582	$7K
80361		<1%	354	$6K
95970		<1%	225	$6K
64447		<1%	40	$6K
11102		<1%	14	$6K
93880		<1%	71	$6K
86765		<1%	732	$6K
90739		<1%	392	$6K
82378		<1%	1,087	$6K
73140		<1%	527	$6K
90632		<1%	297	$6K
86880		<1%	602	$6K
97813		<1%	369	$6K
84436		<1%	1,007	$6K
80050	General health panel	<1%	711	$6K
80178		<1%	456	$6K
82525		<1%	500	$6K
77387		<1%	170	$6K
76942		<1%	433	$6K
86644		<1%	844	$6K
86231		<1%	485	$6K
86015		<1%	410	$6K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	4,568	$6K
93321		<1%	53	$6K
92567		<1%	860	$6K
80177		<1%	994	$5K
88738		<1%	828	$5K
74430		<1%	68	$5K
87906		<1%	58	$5K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	28	$5K
A0429	Emergency ambulance ride, basic life support	<1%	46	$5K
93225		<1%	51	$5K
90633		<1%	779	$5K
84154		<1%	493	$5K
J2800	Injection, methocarbamol, up to 10 ml	<1%	1,414	$5K
86645		<1%	589	$5K
J7328	Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg	<1%	210	$5K
87529		<1%	233	$5K
93298		<1%	351	$5K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	25	$5K
85046		<1%	2,388	$5K
84132		<1%	3,121	$5K
0003A		<1%	135	$5K
70250		<1%	147	$5K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	1,647	$5K
80365		<1%	705	$5K
G0239	Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)	<1%	604	$5K
86593		<1%	752	$5K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,808	$5K
74174		<1%	66	$5K
90662		<1%	619	$5K
83010		<1%	891	$4K
84155		<1%	1,911	$4K
96411		<1%	274	$4K
82977		<1%	871	$4K
88304		<1%	842	$4K
85732		<1%	1,239	$4K
97130		<1%	90	$4K
80346		<1%	228	$4K
88312		<1%	554	$4K
73100		<1%	149	$4K
58300		<1%	97	$4K
82103		<1%	566	$4K
84460		<1%	968	$4K
96401		<1%	137	$4K
76821		<1%	116	$4K
84450		<1%	576	$4K
82947		<1%	2,597	$4K
86258		<1%	517	$4K
86037		<1%	289	$4K
82390		<1%	555	$4K
G0009	Administration of pneumococcal vaccine	<1%	2,962	$4K
80329		<1%	1,964	$4K
85379		<1%	1,314	$4K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,562	$4K
73000		<1%	161	$4K
82140		<1%	658	$4K
82785		<1%	299	$3K
76775		<1%	29	$3K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,715	$3K
80193		<1%	288	$3K
86826		<1%	310	$3K
72158		<1%	14	$3K
75565		<1%	114	$3K
84590		<1%	333	$3K
62370		<1%	61	$3K
90746		<1%	184	$3K
86256		<1%	421	$3K
90723		<1%	880	$3K
97803		<1%	31	$3K
88313		<1%	471	$3K
85613		<1%	720	$3K
82088		<1%	205	$3K
84446		<1%	370	$3K
93290		<1%	806	$3K
D0230	Intraoral - periapical each additional radiographic image	<1%	468	$3K
77399		<1%	39	$3K
51702		<1%	138	$3K
90716		<1%	338	$3K
G0010	Administration of hepatitis b vaccine	<1%	858	$3K
87493		<1%	122	$3K
S9445	Patient education, not otherwise classified, non-physician provider, individual, per session	<1%	67	$3K
82150		<1%	887	$3K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,863	$3K
64415		<1%	21	$3K
78434		<1%	61	$3K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	774	$3K
36592		<1%	143	$3K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	35	$3K
86777		<1%	406	$3K
58100		<1%	14	$3K
84295		<1%	2,154	$3K
85670		<1%	769	$3K
86381		<1%	332	$3K
88112		<1%	527	$3K
93923		<1%	32	$3K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	35	$3K
80349		<1%	378	$3K
85018		<1%	3,022	$3K
D2331		<1%	21	$3K
86665		<1%	369	$3K
82172		<1%	264	$3K
84432		<1%	175	$2K
76377		<1%	292	$2K
96138		<1%	156	$2K
90707		<1%	389	$2K
92504		<1%	993	$2K
97602		<1%	25	$2K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,815	$2K
J1815	Injection, insulin, per 5 units	<1%	1,253	$2K
82247		<1%	386	$2K
J9190	Injection, fluorouracil, 500 mg	<1%	959	$2K
J2785	Injection, regadenoson, 0.1 mg	<1%	684	$2K
77077		<1%	205	$2K
84300		<1%	769	$2K
82952		<1%	224	$2K
90681		<1%	578	$2K
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	27	$2K
89051		<1%	1,008	$2K
86902		<1%	253	$2K
Q3014	Telehealth originating site facility fee	<1%	1,569	$2K
94727		<1%	53	$2K
85384		<1%	1,326	$2K
82164		<1%	187	$2K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,262	$2K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	367	$2K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,276	$2K
82436		<1%	445	$2K
76604		<1%	19	$2K
86304		<1%	528	$2K
85520		<1%	702	$2K
86301		<1%	258	$2K
83525		<1%	150	$2K
0134A		<1%	52	$2K
88237		<1%	17	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,189	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,624	$2K
74019		<1%	42	$2K
75984		<1%	114	$2K
87015		<1%	896	$1K
80158		<1%	194	$1K
96133		<1%	107	$1K
82610		<1%	274	$1K
91322		<1%	405	$1K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	1,467	$1K
0054A		<1%	147	$1K
01400		<1%	17	$1K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,575	$1K
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	1,018	$1K
94621		<1%	14	$1K
96139		<1%	136	$1K
82040		<1%	486	$1K
82010		<1%	543	$1K
J9267	Injection, paclitaxel, 1 mg	<1%	477	$1K
95874		<1%	586	$1K
20552		<1%	17	$1K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,415	$1K
0013A		<1%	43	$1K
84144		<1%	72	$1K
73501		<1%	88	$1K
73080		<1%	67	$1K
90700		<1%	303	$1K
J9206	Injection, irinotecan, 20 mg	<1%	80	$1K
J8540	Dexamethasone, oral, 0.25 mg	<1%	3,368	$1K
0071A		<1%	32	$1K
92133		<1%	183	$1K
84207		<1%	160	$1K
84681		<1%	219	$1K
82310		<1%	152	$1K
97163		<1%	35	$1K
82085		<1%	122	$1K
0064A		<1%	41	$1K
87503		<1%	73	$1K
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	633	$1K
82104		<1%	115	$1K
88173		<1%	225	$1K
C1769	Guide wire	<1%	525	$1K
J1953	Injection, levetiracetam, 10 mg	<1%	126	$1K
84133		<1%	422	$1K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	16	$1K
00190		<1%	91	$1K
85347		<1%	1,184	$1K
C9113	Injection, pantoprazole sodium, per vial	<1%	299	$996.81
J3411	Injection, thiamine hcl, 100 mg	<1%	598	$984.12
87102		<1%	364	$974.28
87350		<1%	172	$956.17
82232		<1%	214	$945.20
81329		<1%	15	$875.75
90696		<1%	135	$856.90
16020		<1%	56	$850.41
82397		<1%	71	$845.81
83519		<1%	110	$845.80
90653		<1%	216	$845.10
81002		<1%	423	$837.67
76376		<1%	72	$833.76
92235		<1%	13	$825.53
86807		<1%	14	$824.15
99201		<1%	41	$794.86
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	138	$770.44
86696		<1%	47	$766.53
80183		<1%	76	$752.23
85240		<1%	41	$751.16
51701		<1%	116	$748.93
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	949	$739.02
85660		<1%	617	$734.82
0031A		<1%	177	$718.32
87075		<1%	634	$706.84
00840		<1%	282	$702.70
77001		<1%	169	$693.99
85390		<1%	628	$686.28
0072A		<1%	18	$685.54
87338		<1%	61	$671.58
64644		<1%	18	$652.34
00320		<1%	92	$649.40
87206		<1%	467	$630.27
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,176	$621.68
J1790	Injection, droperidol, up to 5 mg	<1%	1,233	$611.59
90710		<1%	164	$611.15
80299		<1%	139	$604.19
87328		<1%	54	$599.91
86707		<1%	78	$590.27
C1830	Powered bone marrow biopsy needle	<1%	95	$588.02
82652		<1%	54	$587.70
90473		<1%	497	$576.63
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,384	$572.19
0051A		<1%	34	$561.12
82542		<1%	38	$546.64
94664		<1%	26	$539.95
87329		<1%	54	$539.04
96368		<1%	87	$515.05
81015		<1%	241	$512.24
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	875	$509.94
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	161	$508.53
86695		<1%	44	$499.34
0012A		<1%	38	$497.52
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	405	$497.20
92081		<1%	13	$496.67
0052A		<1%	51	$483.92
J2060	Injection, lorazepam, 2 mg	<1%	1,244	$478.12
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	18	$474.12
J1453	Injection, fosaprepitant, 1 mg	<1%	21	$468.35
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	394	$466.16
C1726	Catheter, balloon dilatation, non-vascular	<1%	53	$463.90
87116		<1%	376	$452.73
36593		<1%	14	$450.05
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	89	$445.04
87177		<1%	30	$434.37
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	462	$417.63
77012		<1%	18	$413.38
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,674	$411.83
83935		<1%	110	$410.52
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	4,124	$409.71
0053A		<1%	16	$393.16
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,102	$389.11
00790		<1%	76	$385.29
87209		<1%	30	$361.44
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	17	$355.18
73521		<1%	12	$354.02
Q2038	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)	<1%	26	$353.35
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	208	$348.63
90688		<1%	29	$334.69
82810		<1%	292	$329.87
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	283	$323.15
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	511	$314.47
J1940	Injection, furosemide, up to 20 mg	<1%	775	$293.32
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	1,640	$287.55
84166		<1%	29	$286.84
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	344	$283.32
95250		<1%	48	$275.76
93799		<1%	15	$257.06
84244		<1%	45	$246.33
29125		<1%	17	$244.20
80335		<1%	19	$236.02
87147		<1%	59	$234.16
Q0114	Fern test	<1%	137	$230.04
76870		<1%	28	$225.94
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	145	$225.05
58301		<1%	40	$216.56
80235		<1%	49	$203.56
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	511	$202.71
S0028	Injection, famotidine, 20 mg	<1%	499	$202.58
82239		<1%	15	$201.62
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	18	$190.53
98960		<1%	14	$188.70
83930		<1%	41	$185.39
87449		<1%	75	$184.65
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	250	$176.14
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	<1%	158	$172.59
J0735	Injection, clonidine hydrochloride, 1 mg	<1%	20	$167.58
C9257	Injection, bevacizumab, 0.25 mg	<1%	42	$166.44
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	387	$150.60
84305		<1%	17	$150.07
80354		<1%	17	$149.60
87184		<1%	43	$145.31
J1630	Injection, haloperidol, up to 5 mg	<1%	795	$142.49
80201		<1%	14	$141.21
92025		<1%	17	$140.26
74021		<1%	26	$136.27
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	54	$135.41
83498		<1%	13	$133.42
84157		<1%	283	$130.65
86705		<1%	22	$120.86
J0736	Injection, clindamycin phosphate, 300 mg	<1%	122	$116.81
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	52	$113.40
86706		<1%	38	$110.89
88302		<1%	27	$108.90
J3590	Unclassified biologics	<1%	24	$108.75
86308		<1%	23	$108.02
88311		<1%	69	$106.95
J0706	Injection, caffeine citrate, 5 mg	<1%	40	$104.22
82985		<1%	17	$102.87
82945		<1%	240	$98.11
J1171	Injection, hydromorphone, 0.1 mg	<1%	300	$95.18
J1836	Injection, metronidazole, 10 mg	<1%	147	$94.04
J9263	Injection, oxaliplatin, 0.5 mg	<1%	123	$85.14
84478		<1%	15	$77.06
0011A		<1%	15	$72.93
J0461	Injection, atropine sulfate, 0.01 mg	<1%	72	$70.77
87305		<1%	42	$70.37
J0280	Injection, aminophyllin, up to 250 mg	<1%	18	$63.94
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	552	$57.49
94760		<1%	237	$53.90
86701		<1%	17	$52.07
86702		<1%	17	$52.07
91300		<1%	6,452	$50.55
80203		<1%	14	$41.71
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	162	$38.63
89060		<1%	32	$35.25
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	203	$28.17
91312		<1%	778	$26.01
82042		<1%	30	$24.24
73565		<1%	16	$21.36
90685		<1%	13	$18.58
87071		<1%	98	$18.19
87176		<1%	28	$14.70
J2470	Injection, pantoprazole sodium, 40 mg	<1%	17	$6.21
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	68	$5.71
91301		<1%	132	$0.81
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	307	$0.77
91305		<1%	288	$0.71
91307		<1%	69	$0.66
91303		<1%	198	$0.25
91313		<1%	52	$0.20
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	38	$0.00
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	0%	116	$0.00
00813		0%	173	$0.00
0866T		0%	14	$0.00
64484		0%	46	$0.00
J2002	Injection, lidocaine hcl in 5% dextrose, 1 mg	0%	22	$0.00
D1208	Topical application of fluoride, excluding varnish	0%	52	$0.00
00160		0%	12	$0.00
00142		0%	18	$0.00
00811		0%	869	$0.00
C1780	Lens, intraocular (new technology)	0%	98	$0.00
S0013	Esketamine, nasal spray, 1 mg	0%	29	$0.00
C1714	Catheter, transluminal atherectomy, directional	0%	126	$0.00
C1874	Stent, coated/covered, with delivery system	0%	13	$0.00
00532		0%	16	$0.00
C1788	Port, indwelling (implantable)	0%	30	$0.00
00812		0%	114	$0.00
C1776	Joint device (implantable)	0%	55	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	49	$0.00
00520		0%	186	$0.00
64636		0%	27	$0.00
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	0%	67	$0.00
90671		0%	76	$0.00
D1999		0%	14	$0.00
00910		0%	36	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	46	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHINDS, HUGH (EXECUTIVE VP & CFO)

Same official

Other billing entities under HINDS, HUGH

Full network →

Provider	Location	Paid
University of Cincinnati Physicians Company, LLC	Cincinnati, OH	$65.09M
West Chester Hospital LLC	West Chester, OH	$19.60M
University Surgical-Dental Associates, LLC	Cincinnati, OH	$8.15M
Daniel Drake Center for Post-Acute Care, LLC	Cincinnati, OH	$5.55M
University of Cincinnati Physicians Company LLC	Cincinnati, OH	$5.47M
University of Cincinnati Medical Center, LLC	Cincinnati, OH	$614K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.